Zhejiang Hisun Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biological and generic drugs in China. The company provides active pharmaceutical ingredients. It also offers its products for anti-tumor, anti-infection, cardiovascular, endocrine, immunosuppression, antidepressant, and orthopedics treatment; nutrition and healthcare; and oncology, ADC small molecule, animal healthcare, and others. The company exports its products to approximately 70 countries worldwide. Zhejiang Hisun Pharmaceutical Co., Ltd. was founded in 1956 and is headquartered in Taizhou, China.
Research context
Zhejiang Hisun Pharmaceutical Co., Ltd appears in PyInvesting’s Shanghai Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CNY
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Zhejiang Hisun Pharmaceutical Co., Ltd is currently in a long term downtrend where the price is trading 7.5% below its 200 day moving average.
From a valuation standpoint, the stock is 86.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.3.
Zhejiang Hisun Pharmaceutical Co., Ltd's total revenue rose by 16.0% to $3B since the same quarter in the previous year.
Its net income has increased by 106.4% to $75M since the same quarter in the previous year.
Finally, its free cash flow grew by 6692.1% to $214M since the same quarter in the previous year.
Based on the above factors, Zhejiang Hisun Pharmaceutical Co., Ltd gets an overall score of 4/5.